Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$36.48 - $52.22 $12.5 Million - $17.9 Million
-342,494 Closed
0 $0
Q4 2021

Jan 13, 2022

BUY
$33.11 - $55.01 $192,501 - $319,828
5,814 Added 1.73%
342,494 $14.9 Million
Q3 2021

Oct 27, 2021

SELL
$50.07 - $66.05 $319,196 - $421,068
-6,375 Reduced 1.86%
336,680 $16.9 Million
Q2 2021

Jul 15, 2021

SELL
$56.61 - $80.46 $11.2 Million - $15.9 Million
-197,565 Reduced 36.54%
343,055 $21.6 Million
Q1 2021

May 11, 2021

SELL
$86.23 - $125.19 $10.1 Million - $14.7 Million
-117,146 Reduced 17.81%
540,620 $50.2 Million
Q4 2020

Feb 04, 2021

BUY
$79.17 - $111.47 $30.8 Million - $43.3 Million
388,709 Added 144.47%
657,766 $58.9 Million
Q3 2020

Nov 09, 2020

BUY
$81.91 - $134.94 $5.99 Million - $9.87 Million
73,161 Added 37.35%
269,057 $27.8 Million
Q2 2020

Aug 14, 2020

SELL
$54.33 - $89.52 $3.48 Million - $5.73 Million
-64,059 Reduced 24.64%
195,896 $15.5 Million
Q1 2020

May 14, 2020

SELL
$49.34 - $68.76 $5.84 Million - $8.15 Million
-118,461 Reduced 31.3%
259,955 $15 Million
Q4 2019

Feb 05, 2020

SELL
$51.21 - $59.06 $15.3 Million - $17.7 Million
-299,212 Reduced 44.16%
378,416 $20.4 Million
Q3 2019

Nov 06, 2019

BUY
$40.6 - $57.2 $4.31 Million - $6.08 Million
106,219 Added 18.59%
677,628 $35.4 Million
Q2 2019

Aug 09, 2019

BUY
$39.92 - $53.86 $1.76 Million - $2.37 Million
44,009 Added 8.34%
571,409 $27.6 Million
Q1 2019

May 13, 2019

BUY
$48.23 - $66.16 $25.4 Million - $34.9 Million
527,400 New
527,400 $26.6 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $515M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Vaughan Nelson Investment Management, L.P. Portfolio

Follow Vaughan Nelson Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan Nelson Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Vaughan Nelson Investment Management, L.P. with notifications on news.